These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25262963)

  • 21. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.
    Grimm W; Plachta E; Maisch B
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitachycardia pacing reduces appropriate and inappropriate shocks in children and congenital heart disease patients.
    Kalra Y; Radbill AE; Johns JA; Fish FA; Kannankeril PJ
    Heart Rhythm; 2012 Nov; 9(11):1829-34. PubMed ID: 22766560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term efficacy of antitachycardia pacing for treatment of ventricular tachycardia in patients with implantable cardioverter/defibrillator].
    Fiek M; Hoffmann E; Dorwarth U; Müller D; Steinbeck G
    Z Kardiol; 1999 Oct; 88(10):815-22. PubMed ID: 10552185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial.
    Saeed M; Neason CG; Razavi M; Chandiramani S; Alonso J; Natarajan S; Ip JH; Peress DF; Ramadas S; Massumi A
    J Cardiovasc Electrophysiol; 2010 Dec; 21(12):1349-54. PubMed ID: 20561107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of signal analyses of ventricular tachycardia electrograms to predict the response of antitachycardia pacing in patients with implantable cardioverter-defibrillators.
    Tuan TC; Lo MT; Lin YJ; Hsieh WH; Lin C; Huang NE; Lo LW; Chao TF; Liao JN; Hsieh YC; Wu TJ; Chen SA
    J Cardiovasc Electrophysiol; 2014 Apr; 25(4):411-417. PubMed ID: 24320556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventricular tachycardia in cardiolaminopathy: Characteristics and considerations for device programming.
    Sidhu K; Han L; Picard KCI; Tedrow UB; Lakdawala NK
    Heart Rhythm; 2020 Oct; 17(10):1704-1710. PubMed ID: 32454220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitachycardia pacing for shock prevention in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
    Dallaglio PD; di Marco A; Moreno Weidmann Z; Perez L; Alzueta J; García-Alberola A; Fernandez-Lozano I; Díaz-Infante E; Rodriguez A; Basterra N; Calvo D; Rodriguez Garcia M; Aceña M; Anguera I
    Heart Rhythm; 2020 Jul; 17(7):1084-1091. PubMed ID: 32113896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
    Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
    J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blocker therapy is associated with a lower incidence of syncope due to fast ventricular tachycardias among implantable cardioverter-defibrillator patients with left ventricular dysfunction: results from a multicenter study.
    Jiménez-Candil J; Anguera I; Durán O; Hernández J; Fernández-Portales J; Moríñigo JL; Martín A; Dallaglio P; Bravo L; di Marco A; Sánchez PL
    J Interv Card Electrophysiol; 2018 Jun; 52(1):69-76. PubMed ID: 29557531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Efficacy of Implantable Cardioverter Defibrillator in Repaired Tetralogy of Fallot　- Role of Anti-tachycardia Pacing.
    Henmi R; Ejima K; Yagishita D; Iwanami Y; Nishimura T; Takeuchi D; Toyohara K; Shoda M; Hagiwara N
    Circ J; 2017 Jan; 81(2):165-171. PubMed ID: 27941299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and characteristics of type-2 breaks in response to antitachycardia pacing therapy in implantable cardioverter defibrillator patients.
    Sharma V; DeGroot PJ; Wathen MS
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1156-62. PubMed ID: 14678127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
    Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of pace-terminated ventricular arrhythmias.
    Pokorney SD; Al-Khatib SM
    Card Electrophysiol Clin; 2015 Sep; 7(3):497-513. PubMed ID: 26304530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-by-patient basis anti-tachycardia pacing for fast ventricular tachycardia with structural heart diseases.
    Chinushi M; Furushima H; Saitoh O; Noda T; Nitta T; Aizawa Y; Ohe T; Kurita T
    Pacing Clin Electrophysiol; 2020 Sep; 43(9):983-991. PubMed ID: 32524624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive implantable cardioverter-defibrillator therapies for ventricular tachycardia: The efficacy and safety of multiple bursts, ramps, and low-energy shocks.
    Strik M; Ramirez FD; Welte N; Bonnin T; Abu-Alrub S; Eschalier R; Haïssaguerre M; Ritter P; Ploux S; Bordachar P
    Heart Rhythm; 2020 Dec; 17(12):2072-2077. PubMed ID: 32739474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal exit site of clinical ventricular tachycardia is an independent predictor of antitachycardia pacing failure in implantable cardioverter-defibrillators recipients.
    Boulé S; Brigadeau F; Marquié C; Salleron J; Klug D; Kouakam C; Guédon-Moreau L; Duhamel A; Acheré C; Wissocque L; Lacroix D; Kacet S
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1209-16. PubMed ID: 22817404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
    Kleemann T; Strauss M; Kouraki K; Zahn R
    Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of intrinsic antitachycardia pacing for ventricular tachycardia refractory to conventional burst pacing: A case series.
    Kamakura T; Ueda N; Wada M; Ishibashi K; Kusano K
    J Cardiovasc Electrophysiol; 2023 Jan; 34(1):225-228. PubMed ID: 36511471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.